title: Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study.
abstract: OBJECTIVE
  Some recent studies have reported the role of cholesterol crystals (ChCs) in plaque rupture in patients with coronary artery disease. We used optical coherence tomography (OCT) to investigate the characteristics of coronary plaques that were associated with derived ChCs.
  
  
  METHODS
  We evaluated 101 subjects with stable coronary artery disease who underwent OCT. We compared the OCT findings of the culprit lesions with ChCs to those without ChCs and investigated the background characteristics.
  
  
  RESULTS
  ChCs were observed in culprit lesions of 39 patients. The frequencies of spotty calcification, microchannel structure, and lipid-rich plaque were significantly higher in patients with ChCs than those without ChCs (64.1 vs. 27.4%, p < 0.001; 69.2 vs. 38.7%, p = 0.003; 53.8 vs. 29.0%, p = 0.01, respectively). On the other hand, the frequencies of thrombus, disruption, and thin-cap fibroatheroma did not differ significantly between patients with and without ChCs (15.3 vs. 24.1%, p = 0.3; 33.3 vs. 17.7%, p = 0.07; and 33.3 vs. 24.1 %, p = 0.3, respectively). Among the possible clinical factors, multivariate analysis showed an elevated level of glycated hemoglobin as the sole significant factor associated with ChCs.
  
  
  CONCLUSIONS
  ChCs are frequently associated with the major findings of vulnerable plaque, and are often seen in poorly controlled diabetic patients. Thus, ChCs might be one of the features of vulnerable plaque.
authors.affiliation: Department of Cardiovascular Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-0022, Japan, s-nakamura@nms.ac.jp.
authors.forename: Shunichi
authors.initials: S
authors.lastname: Nakamura
authors.forename: Shigenobu
authors.initials: S
authors.lastname: Inami
authors.forename: Koji
authors.initials: K
authors.lastname: Murai
authors.forename: Masamichi
authors.initials: M
authors.lastname: Takano
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Takano
authors.forename: Kuniya
authors.initials: K
authors.lastname: Asai
authors.forename: Masahiro
authors.initials: M
authors.lastname: Yasutake
authors.forename: Wataru
authors.initials: W
authors.lastname: Shimizu
authors.forename: Kyoichi
authors.initials: K
authors.lastname: Mizuno
mesh_terms: D000368:Aged; D002784:Cholesterol / Q000737:chemistry*; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000378:metabolism; D003331:Coronary Vessels / Q000378:metabolism / Q000473:pathology*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D058226:Plaque, Atherosclerotic / Q000175:diagnosis* / Q000378:metabolism; D015203:Reproducibility of Results; D012720:Severity of Illness Index; D041623:Tomography, Optical Coherence / Q000379:methods*
chemical_list: D002784:Cholesterol
references.citation: Nat Med. 2011 Jul 10;17(8):1010-4
references.pmid: 21743452
references.citation: Am J Cardiol. 2011 Jun 15;107(12):1710-7
references.pmid: 21507364
references.citation: JAMA. 2001 Apr 4;285(13):1711-8
references.pmid: 11277825
references.citation: Atherosclerosis. 2009 Mar;203(1):89-96
references.pmid: 18703195
references.citation: N Engl J Med. 2003 Dec 11;349(24):2316-25
references.pmid: 14668457
references.citation: N Engl J Med. 1998 Jul 23;339(4):229-34
references.pmid: 9673301
references.citation: Nature. 2010 Apr 29;464(7293):1357-61
references.pmid: 20428172
references.citation: Am J Cardiol. 2009 Apr 1;103(7):959-68
references.pmid: 19327423
references.citation: Circulation. 2003 Jan 28;107(3):499-511
references.pmid: 12551878
references.citation: JACC Cardiovasc Interv. 2012 Nov;5(11):1150-8
references.pmid: 23174639
references.citation: Diabetes. 1974 Feb;23(2):105-11
references.pmid: 4359625
references.citation: Atherosclerosis. 2009 Feb;202(2):491-7
references.pmid: 18572175
references.citation: Clin Cardiol. 2005 Sep;28(9):413-20
references.pmid: 16250264
references.citation: N Engl J Med. 2004 Apr 8;350(15):1495-504
references.pmid: 15007110
references.citation: Eur Heart J. 2009 Jun;30(11):1348-55
references.pmid: 19383736
references.citation: Circulation. 2004 Nov 30;110(22):3424-9
references.pmid: 15557374
references.citation: J Am Coll Cardiol. 2012 Mar 20;59(12):1058-72
references.pmid: 22421299
references.citation: PLoS One. 2010 Jul 23;5(7):e11765
references.pmid: 20668705
references.citation: J Clin Lipidol. 2010 May-Jun;4(3):156-64
references.pmid: 21122648
references.citation: JACC Cardiovasc Imaging. 2009 Mar;2(3):339-49
references.pmid: 19356580
references.citation: Circulation. 1995 Nov 1;92(9):2419-25
references.pmid: 7586340
references.citation: Arterioscler Thromb Vasc Biol. 2000 May;20(5):1262-75
references.pmid: 10807742
references.citation: J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C13-8
references.pmid: 16631505
references.citation: Circ Cardiovasc Imaging. 2011 Mar;4(2):169-78
references.pmid: 21406663
references.citation: J Invasive Cardiol. 2010 Sep;22(9):406-11
references.pmid: 20814046